Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Share News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -4.00 (-0.76%)
Bid:
521.00
Ask:
522.00
Spread: 1.00 (0.192%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Galliford Try News

SMALL-CAP WINNERS & LOSERS: Avon Protection plates face approval delay
12 Nov 2021

SMALL-CAP WINNERS & LOSERS: Avon Protection plates face approval delay

SMALL-CAP WINNERS & LOSERS: Avon Protection plates face approval delay

Galliford Try 'performing well', confident of meeting FY objectives
12 Nov 2021

Galliford Try 'performing well', confident of meeting FY objectives

(Sharecast News) - Construction firm Galliford Try said on Friday that group operations were "performing well", with margins in line with internal exp...

LONDON MARKET PRE-OPEN: Astra revenue up; Wood reviews Consulting unit
12 Nov 2021

LONDON MARKET PRE-OPEN: Astra revenue up; Wood reviews Consulting unit

LONDON MARKET PRE-OPEN: Astra revenue up; Wood reviews Consulting unit

UK shareholder meetings calendar - next 7 days
5 Nov 2021

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

UK dividends calendar - next 7 days
4 Nov 2021

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

EXECUTIVE CHANGES: Carr's CEO departs after 9 mos; Vistry CEO to stay
12 Oct 2021

EXECUTIVE CHANGES: Carr's CEO departs after 9 mos; Vistry CEO to stay

EXECUTIVE CHANGES: Carr's CEO departs after 9 mos; Vistry CEO to stay

TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit
7 Oct 2021

TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit

TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit

TRADING UPDATES: Galliford signs LHC deal; Polarean turned down by FDA
6 Oct 2021

TRADING UPDATES: Galliford signs LHC deal; Polarean turned down by FDA

TRADING UPDATES: Galliford signs LHC deal; Polarean turned down by FDA